We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.00 | 17.50 | 18.50 | 18.00 | 18.00 | 18.00 | 66,018 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.34 | 16.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
29/5/2019 22:27 | Disappointing to see people being critical of how much someone can afford to invest. Says a lot about them. Fred didn't buy shares to make you insecure folk feel more confident in your investment. He has his own life, agenda and circumstances. Respect that. | thenightfox | |
29/5/2019 22:23 | We know OPTI are in multiple negotiations left, right and centre. If a deal lands they have to announce it to the market asap. Director deals are irrelevant. | someuwin | |
29/5/2019 22:10 | At the end of the recent interview SOH says... “exciting month was May now let’s hope we can do just as well or even better in June” Let’s see what the month of June has in store. The share price does not necessarily need news to go up, as we witnessed last summer. I think the anticipation of news can drive the price more than the news itself. And then at some point we will see a blockbuster announcement 😃 | parob | |
29/5/2019 22:04 | Can news come out regarding other divisions that he's not involved in I wonder? | robo28 | |
29/5/2019 22:00 | I was not moaning. Just wanted to know if the small share purchase by a director meant no news for several weeks. I think it does mean no news, but then hopefully followed by a Tata et al news release towards the end of June. But I do hope I’m wrong and we get something to keep momentum going shortly. If we don’t, it’s the usual retraction in share price I guess. | imnotlong | |
29/5/2019 19:08 | In other news, the Seed probiotic is featured in New York magazine:CELEBRITY SHOPPING 4:43 P.M.What Tamara Mellon Can't Live WithouthTTp://nymag. | parob | |
29/5/2019 18:05 | Also seems to be a common occurrence new directors buying in soon after appointments. Sean Christie, Neil Davidson & now Fred Narbel all industry heavyweights. They've put in nearly £500k between them & they know what the opportunities are. If that's not confidence then I do not know what is! Now with another heavyweight with Steve Prescott for Probiotix this company is going places without a doubt. | riskybusiness1 | |
29/5/2019 17:39 | Exactly James! Some people moan constantly! | primal123 | |
29/5/2019 17:39 | You are totally wrong. But believe what you think is right. As I said no one knows his finances etc but I can assure you that this is very positive! | primal123 | |
29/5/2019 17:25 | Nice one Fred. A step in the right direction. It shows confidence in what you’re doing and gives confidence to others not only to buy in at this price but to top up while you have the chance. Can’t believe some people moan about positive actions. Get a grip. | jamesrs1 | |
29/5/2019 17:23 | On appointment, the general consensus was that he's pretty experienced - so already well established in his career. Given this, I don't see 12,000 shares at 89p being a significant vote of confidence. Nor a bad signal. Just a bit of a non-event really and not something we should read much into either way. | lord loads of lolly | |
29/5/2019 17:16 | The main thing is he's buying shares at a high price showing confidence. £11k is £11k. He has 500k shares as Options so effectively he's increasing his future stake before his performance related options vest once he achieved his targets. Fact is he's putting his cash in when he doesn't really need to buy any because of those options.I'd also add the amount could be any number of reasons. For all you know he's moving house or something so has little spare cash but really wants to buy some before things get going. To say 'why bother' is just a mindless thing to say.Also as full year results have already been announced & interims a little while off I'm pretty sure this is one of only a few times during the year directors can buy. | riskybusiness1 | |
29/5/2019 17:04 | Guys, what on earth are you moaning at? He has put his hard earned cash in! Do those who are criticising know where Fred is with his career, what his finances are like? No. Not everyone has 10s of thousands to put in a share when they are trying to build their career! | primal123 | |
29/5/2019 16:55 | Poultry as may be Lodger, he could have chickened out, could he not? | owenmo | |
29/5/2019 16:48 | I can't believe the moaning about Narbel. Are the critics aware of his personal financial commitments, expenditure, relocation costs etc? Some idiots will moan about anything, give it a rest ffs. | dire cons | |
29/5/2019 16:47 | Wish some folk would realise that not everyone has 20k or 50k to spend on shares ... even directors. 11k is tlpretty reasonable and suspect will see more in time. Chill. | meganxmas | |
29/5/2019 16:44 | fk me ..god forbid anyone let this go up 2p without running for the exit | onedayrodders | |
29/5/2019 16:42 | It's a poultry amount for a director to buy, it's lilke faint praise. | lodger | |
29/5/2019 16:28 | It's better than owt. At least that's now three directors who are in and aligned with shareholders at a personal financial level - all of whom have bought in the open market. All good in my eyes. | colinzeal | |
29/5/2019 16:26 | Exudes it :) | judijudi | |
29/5/2019 16:23 | If it's £11000 of his own money it shows confidence! | malreid | |
29/5/2019 16:15 | He shouldn't have bothered. | lodger | |
29/5/2019 16:06 | Not even £11,000's worth Bit embarrassing to be honest | judijudi | |
29/5/2019 16:04 | That’s two years away I suspect. | rafboy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions